RefE-252

Entered

Figures4 min · 859 words

Working paper

JOST Lifts 2026 Outlook as Q3 Sales Rise 11% to EUR 426 Million

JOST raised 2026 guidance after Q3 sales rose 11% to EUR 426 million and adjusted EBIT grew 12% to EUR 42 million, but China, freight costs and delayed price pass-through cloud the outlook.

Exhibit AWhat JOST Werke (JST) Said on Its Q3 Earnings Call
What JOST Werke (JST) Said on Its Q3 Earnings Call — Quanlecntt2004 / pixabay

JOST Werke (ETR:JST) raised its 2026 guidance after third-quarter sales climbed more than 11% to EUR 426 million and adjusted EBIT rose 12% to nearly EUR 42 million. The truck and trailer components maker now expects 2026 sales growth of 9% to 11% from EUR 1.534 billion in 2025, with adjusted EBIT up 11% to 14% from EUR 145 million and a margin of 9.5% to 9.9%. Every promise in that guidance, however, rests on assumptions management itself flagged as uncertain.

What did the quarter deliver?

The adjusted EBIT margin improved 0.1 percentage point to 9.8% in the third quarter. Over the first nine months, sales rose 12% to EUR 1.284 billion and adjusted EBIT increased 18% to EUR 130 million, lifting the margin to 10.1% from 9.6%. Organic growth ran at 9% in both periods — a solid figure, though it means acquisitions supplied the remainder of the reported increase.

Chief Executive Officer Joachim Dürr said cost synergies more than offset the quarter's higher freight and material expenses. That claim holds at the group level. It does not hold in Europe, as the regional numbers show.

Which regions carried the results?

  • Americas: Sales rose almost 20% to EUR 127 million, roughly 15% excluding currency effects. Adjusted EBIT jumped to more than EUR 18 million from EUR 10.9 million, with the margin at 14.5%.
  • Europe, Middle East and Africa: Sales grew 2.5% to EUR 187 million, but adjusted EBIT fell to EUR 7.1 million from EUR 11.4 million. The margin dropped to 3.8% from 6.3%.
  • Asia-Pacific: Sales rose almost 19% reported and 15% organically. Adjusted EBIT edged up to EUR 14.9 million from EUR 13.9 million; the margin slipped to 13.2% from 14.7%.

CFO Oliver Gantzert attributed the Americas gain to stronger factory utilization in the transport business, cross-selling synergies from the Hyva integration, and a smaller benefit from rerouting sales between regions. Note the mechanism: part of the Americas uplift came at EMEA's expense, since the rerouting moved profitable sales out of Europe.

Dürr said North American Class 8 truck production rose 54% year over year, aided by purchases ahead of anticipated emissions-related costs and pent-up demand after tariff-related build cuts. He also warned that some manufacturers face component supply constraints that may block planned production. A 54% surge built partly on pull-forward demand rarely repeats; JOST said only that it stands ready to support customers.

In EMEA, Gantzert cited higher freight and input costs, temporary inefficiencies from a site closure, and the sales rerouting. In Asia-Pacific, strong Indian hydraulics demand forced imports from China, adding freight costs and import duties until local capacity expands.

What did management say about China and 2027?

Gantzert said the pace of any slowdown in China's export economy would determine where results land within the guidance range. October sales from China remained strong, though he acknowledged initial signs of normalization — a caveat attached directly to the raised outlook.

For 2027, Gantzert said JOST expects sales growth even after disposing of its Indian tipper body business, anticipating strong growth in the Americas and solid growth in EMEA, with China relatively flat. Dürr added that JOST expected continued market growth in India.

How solid are cash flow and the balance sheet?

Free cash flow reached EUR 7 million in the quarter and EUR 23 million for nine months. Net debt stood at EUR 381 million, or 1.78 times leverage. Adjusted net income for the nine months rose to EUR 74 million from EUR 64 million, despite a EUR 3.8 million one-off tax expense from an Asian tax audit settlement.

Gantzert said working capital rose mainly on growth, project ramp-ups and safety stocks. He expects some fourth-quarter reduction but conceded cash conversion will not match last year's unusually high level. He also said the European site closure, Indian import costs and inflation weigh on fourth-quarter performance — though he does not expect these issues to persist through 2027.

Cost recovery lags the pressure. Dürr said OEM contracts typically allow cost-related price adjustments after three to six months, with first effects in first-quarter 2027 results and potentially the full effect in the second quarter. Until then, margins carry the burden.

What changed in the portfolio?

JOST acquired the remaining 25% of Brazilian sanitation equipment maker Usimeca for approximately EUR 17 million, effective Oct. 15, after the seller exercised a put option. Gantzert said Usimeca operates above a 14% EBIT margin and adds to earnings per share immediately.

JOST also agreed to sell its Indian tipper body business to Belrise. Gantzert called the unit low-margin and working-capital-intensive, saying the sale lets JOST focus on cylinders and hydraulics in India. He expects closing by year-end, but allowed it could slip into the first weeks of 2027.

The guidance raise is real, and so are its hinges: a China cycle turning, cost pass-through arriving two quarters late, and an Americas boom partially borrowed from the future.

Audit trail

  1. Q3 sales rose more than 11% to EUR 426 million; adjusted EBIT up 12% to nearly EUR 42 million.
  2. 2026 guidance raised: sales up 9-11% from EUR 1.534 billion; adjusted EBIT up 11-14% from EUR 145 million.
  3. Americas Q3 adjusted EBIT rose to over EUR 18 million from EUR 10.9 million; EMEA margin fell to 3.8% from 6.3%.
  4. Net debt stood at EUR 381 million, leverage of 1.78 times; nine-month free cash flow was EUR 23 million.
  5. JOST bought the remaining 25% of Usimeca for about EUR 17 million and agreed to sell its Indian tipper body business to Belrise.

via dailypolitical.com (Source)

Filed under

  • jost-werke
  • jost-q3-results
  • guidance
  • adjusted-ebit
  • usimeca-acquisition
Share this article:

More from Tom Whitfield

Tom Whitfield

Show full bio

News editor covering companies, deals and strategy in corporate finance and the leaders who run it at CFO Observer.

232 articles

Cross-references

« Previous article